Repros Therapeutics Inc (RPRX)

[iwfal]

Just so we are clear, I have no issue with BSR and their (implied) actions in this matter. In fact authors of investor stock newsletters make a living "finding" and releasing such nuggets. The onus is entirely on the regulated company (i.e. Repros) to not selectively disclose such information in the first place.

Suggest this is a gray areas - if a company willingly and expeditiously answers questions from all quarters do they have to do it publicly? Repros is about as willing as any company I've seen to answer specific technical questions from investors. For example, per DocBanker's post he called the company and got much of the same info that HPTAxis published. (note that I realize DocBanker is another investment industry person - but there are plenty of other examples apparent elsewhere on this board. I just can't list them offhand.)